# Open-Label Extension Study to ZPE-202

> **NCT01961908** · PHASE2 · WITHDRAWN · sponsor: **Repros Therapeutics Inc.**

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Proellex

## Key facts

- **NCT ID:** NCT01961908
- **Lead sponsor:** Repros Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01961908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01961908, "Open-Label Extension Study to ZPE-202". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01961908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*